There were six candidate missense variants in the following cancer genes: MSH2, APC, PTPN12, BMPR1A, POLE, and SRC, and one inframe duplication in BRIP1. All were classified as variants of unknown significance according to ACMG criteria (Table 1). This evidence concerns the gene POLE and cancer.